Latest News
Figures released by EMPEA show that between 2006 and Q3 2015, fund managers raised over USD432 billion via long-term, private direct investment funds, for the emerging markets of Africa, Asia, Europe, Latin America and the Middle East.
The investments, all backed by institutional investors, were across three asset classes – private equity, private infrastructure and real assets and private credit.
Robert van Zwieten, President & CEO of EMPEA, says: “The USD432-plus billion raised for private funds is a milestone for emerging economies and a significant achievement for fund managers putting capital to work in places most in need of
Pt Capital has held the initial close of its inaugural private equity fund, Pt Arctic Fund I with commitments of over USD125 million.
Pt Capital, a private equity firm headquartered in Alaska, is focused exclusively on the emerging market of the Arctic. The Fund intends to invest in and grow, companies in Alaska, Canada, Greenland and Iceland in a broad set of industries. A diversified group of global investors and Arctic indigenous-owned businesses have invested in the Fund.
Hugh Short, an Inupiat Eskimo, who serves as the Chairman and CEO, says: "Pt Capital connects regional stakeholders, indigenous businesses, and
Lonsdale Capital Partners, a private equity firm focussed on the smaller end of the market, has made its third hire of the year with the appointment of Richard Pindar as an Associate.
Pindar joins Lonsdale Capital Partners from KPMG where he trained and qualified as a Chartered Accountant in 2014. He spent time in Corporate Finance, working on transactions in a lead advisory role, and Transaction Services, where he performed financial due diligence on behalf of private equity clients.
He will be working across the business, focusing on deal origination and implementation, as well as supporting the existing portfolio
Excellere Partners, a Denver-based private equity firm specialising in partnering with entrepreneurs and management teams through recapitalisations and management buyouts, has hired Michael Geldart as Partner.
David Kessenich, Managing Partner and Co-Founder of Excellere Partners, says: “We are excited to welcome Michael to Excellere Partners. He is a strategic-minded, results-oriented leader with an entrepreneurial mindset. With his vast healthcare experience in legal, regulatory compliance and operations, Michael will be an extremely value-added team member to our current and future healthcare investments.”
Geldart has more than 20 years of experience in executive leadership, health law, and corporate development. Most recently,
Edge Investments, a creative industries investor, has raised a new £GBP0m fund, with UK Government support, to invest in high growth companies in the creative industries.
Edge’s new Edge Creative Enterprise Fund brings together private sector funding from leading institutions and high net worth individuals, with a significant investment from the Government’s British Business Bank.
Edge Creative Enterprise Fund’s purpose is to nurture and assist creative businesses to grow. By their nature, many of these companies start with a small number of employees, and a high degree of entrepreneurial flair. Edge provides the crucial capital and mentoring skills to
Cairngorm Capital has appointed Alex Bayliss and John Naylor-Leyland as Investment Directors, further bolstering the firm’s capacity for new investments.
Bayliss brings extensive experience of investing in mid market manufacturing and business services companies. He joins from SEA Equity where he was a founding Partner and board member of portfolio company, Vacuum Furnace Engineering. Prior to SEA Equity, Bayliss worked with Cairngorm Capital’s Managing Partner, Andrew Steel, at HIG Capital in London, where he was involved in numerous equity investments and bolt-on acquisitions.
Naylor-Leyland joins from Disruptive Capital, where he was a Partner and led the growth financing of
Scottish-based business angel syndicate, Archangels, and the Scottish Investment Bank (SIB) have supported the investment of a further GBP2m in three growing Scottish businesses in the third quarter of 2015.
The companies – NCTech, Zonefox and ATEEDA – have been supported by Archangels, along with the SIB, from early stage and their investment will be used to fund further growth. Around 50 of Archangels’ investor members chose to participate in these funding rounds.
Edinburgh-based NCTech designs and manufactures leading 360 degree reality imaging systems that automate and streamline image documentation and can be used repeatedly, accurately and consistently by
Why are co-investments becoming so prominent in the world of private equity? The performance of co-investments is analysed in this extract from the recently released Preqin Special Report: Private Equity Co-Investment Outlook, which draws upon a survey of 320 active GPs and 222 active LPs.
The most common response for perceived benefits of co-investing from an LP perspective was the prospect of better returns, so naturally investors will be anticipating a notable outperformance from co-investments compared with their traditional private equity fund commitments. As shown in Fig 1, of those LPs surveyed, 36 per cent expect co-investments to outperform
New York-based private equity firm Harvest Partners has completed the sale of AxelaCare Health Solutions to OptumRx, the pharmacy care services business of Optum. Terms of the transaction have not been disclosed.
Harvest initially invested in the company in April 2013.
AxelaCare is a provider of specialty home infusion services based in Lenexa, Kansas. The company currently treats patients in 44 states and Washington, DC through its network of owned and contracted RNs. The company offers chronic drug therapies for conditions such as autoimmune disease and haemophilia as well as acute infusion therapies, such as antibiotics and total parenteral
Audax Group has held the final close of Audax Private Equity Fund V at its hard cap of USD2.25 billion of aggregate committed capital from a select group of institutional and high-net worth limited partners.
The fund was oversubscribed and exceeded its fundraising target of USD1.75 billion.
Consistent with its predecessor private equity funds, Fund V will continue Audax’ proven strategy of investing in middle-market companies across a select group of industries and will pursue a Buy & Build strategy that seeks to transform smaller companies into strategic assets.
Since its founding in 1999, Audax has raised USD12
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
